Psychosocial interventions show promise for managing non-physiological menopausal symptoms

Interventions such as mindfulness and cognitive behavioral therapy (CBT), could be an effective treatment option for menopause-related mood symptoms, memory and concentration problems, finds a new study by UCL researchers.

European drug regulator rejects Alzheimer’s drug Leqembi, citing safety concerns

The European Medicines Agency on Friday held its ground against anti-amyloid treatments, saying it will not recommend Eisai and Biogen’s Alzheimer’s drug Leqembi for approval

July 27, 2024

AI-enabled self-referral system may bridge the accessibility gap for ethnic and gender minorities in mental health treatment

Researchers assessed the impact of an artificial intelligence (AI)-powered self-referral chatbot on diversity and volume of patient referrals in gender, ethnicity, and sexual orientation.

February 5, 2024

Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.